Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer

Fig. 3

Human prostate cancer cells express lower levels of ADAM19 than normal prostate epithelial cells. a Western blotting for ADAM19 protein in androgen-sensitive human LNCaP cells and RWPE-1 cells. β-actin was used as a control. b ADAM19 protein expression in LNCaP and RWPE-1 cells as determined by immunocytochemistry. 100x magnification. Insert shows cytoplasmic staining

Back to article page
\